Yingchang Mi

Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia

Qi Zhang, Bridget Riley‐Gillis, Lina Han et al. · Signal Transduction and Targeted Therapy · 2022 · 168 citations · Full text

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial

Jie Jin, Jianxiang Wang, Feifei Chen et al. · The Lancet Oncology · 2013 · 157 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +9

Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia

Runxia Gu, Fang Liu, Dehui Zou et al. · Journal of Hematology & Oncology · 2020 · 107 citations · Full text

Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin

Yingchang Mi, Shelia D. Thomas, Xiaohua Xu et al. · Journal of Biological Chemistry · 2003 · 94 citations · Full text

Mixed-phenotype Acute Leukemia, Apoptosis, Cell Death +16

TBLR1 fuses to retinoid acid receptor α in a variant t(3;17)(q26;q21) translocation of acute promyelocytic leukemia

Yirui Chen, Shouyun Li, Chunlin Zhou et al. · Blood · 2014 · 65 citations · Full text